STRS Ohio’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-900
| Closed | -$16K | – | 1957 |
|
|
2017
Q4 | $16K | Sell |
900
-53,400
| -98% | -$657K | ﹤0.01% | 1827 |
|
|
2017
Q3 | $640K | Sell |
54,300
-6,600
| -11% | -$74K | ﹤0.01% | 1246 |
|
|
2017
Q2 | $639K | Buy |
60,900
+15,600
| +34% | +$159K | ﹤0.01% | 1211 |
|
|
2017
Q1 | $498K | Hold |
45,300
| – | – | ﹤0.01% | 1331 |
|
|
2016
Q4 | $613K | Sell |
45,300
-4,500
| -9% | -$62.8K | ﹤0.01% | 1257 |
|
|
2016
Q3 | $613K | Sell |
49,800
-9,600
| -16% | -$113K | ﹤0.01% | 1190 |
|
|
2016
Q2 | $651K | Hold |
59,400
| – | – | ﹤0.01% | 1104 |
|
|
2016
Q1 | $649K | Buy |
59,400
+18,100
| +44% | +$229K | ﹤0.01% | 1066 |
|
|
2015
Q4 | $714K | Buy |
41,300
+6,900
| +20% | +$124K | ﹤0.01% | 1023 |
|
|
2015
Q3 | $683K | Sell |
34,400
-9,400
| -21% | -$216K | ﹤0.01% | 1065 |
|
|
2015
Q2 | $719K | Sell |
43,800
-4,100
| -9% | -$71.1K | ﹤0.01% | 1126 |
|
|
2015
Q1 | $745K | Sell |
47,900
-3,000
| -6% | -$46.5K | ﹤0.01% | 988 |
|
|
2014
Q4 | $727K | Sell |
50,900
-40,900
| -45% | -$432K | ﹤0.01% | 1017 |
|
|
2014
Q3 | $597K | Buy |
91,800
+2,900
| +3% | +$19.3K | ﹤0.01% | 1110 |
|
|
2014
Q2 | $613K | Sell |
88,900
-3,000
| -3% | -$21.2K | ﹤0.01% | 1155 |
|
|
2014
Q1 | $657K | Buy |
91,900
+11,300
| +14% | +$96.7K | ﹤0.01% | 1031 |
|
|
2013
Q4 | $758K | Sell |
80,600
-39,600
| -33% | -$283K | ﹤0.01% | 953 |
|
|
2013
Q3 | $750K | Buy |
120,200
+52,410
| +77% | +$327K | ﹤0.01% | 1043 |
|
|
2013
Q2 | $446K | Buy |
+67,790
| New | +$538K | ﹤0.01% | 1314 |
|
Other funds holding SCMP
STRS Ohio's SCMP Position: Q1 2018 in Review
STRS Ohio sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 900 shares — an estimated $16K sold.
STRS Ohio first reported a position in SCMP in Q2 2013 and held it in 19 quarters. The position peaked at $758K in Q4 2013. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.
- STRS Ohio reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
- STRS Ohio sold 900 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $16K.
- STRS Ohio first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 19 quarters.
- STRS Ohio's Sucampo Pharmaceuticals, Inc. position peaked at $758K in Q4 2013.
- 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.
Based on STRS Ohio's 13F filing for Q1 2018, filed 20 Apr 2018.